We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAAA.L Regulatory News (AAA)

  • There is currently no data for AAA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Unaudited financial statements -period to 11.12.20

15 Dec 2020 15:32

RNS Number : 7571I
All Active Asset Capital Limited
15 December 2020
 

15 December 2020

 

All Active Asset Capital Limited

('AAA' or 'the Company')

 

Unaudited financial statements for the period ended 11 December 2020

 

All Active Asset Capital (AIM:AAA), announces its unaudited financial statements for the period ended 11 December 2020. Due to the significant placings undertaken by AAA since the publication on 30 September 2020 of its unaudited interim financial statements for the six months ended 30 June 2020, the directors are publishing a further set of consolidated financial statements for the period from 1 July 2020 to 11 December 2020 and a consolidated statement of financial position as at 11 December 2020, in order that shareholders and the wider market have an up-to-date understanding of the Company's improved financial position, with total assets increasing to £13.7m as at 11 December 2020 from £2.8m as at 30 June 2020.

 

AAA has not changed its accounting reference period and will be publishing an audited annual report and financial statements for the year ending 31 December 2020 in due course, in accordance with the requirements of the AIM Rules for Companies.

 

There is no current intention to publish further periodic financial position statements, but, if there are similar transformational transactions in the future, the directors may choose to do so in order to assist shareholders and the wider market in their appreciation of the Company's financial position.

 

During the period from 1 July 2020 to 11 December 2020, in addition to the placings described above (which were accompanied by the grant of a total of 71,875,000 warrants to subscribe for new ordinary shares in the Company exercisable at 15p per ordinary share), the Company provided a secured convertible €3.0m loan to MESH Holdings plc and granted a further 49,200,000 warrants to subscribe for new ordinary shares, exercisable at 15p per ordinary share. Since 30 June 2020, 54,670,001 warrants exercisable at 2.5p per ordinary share and 1,562,500 warrants exercisable at 0.4p per ordinary share have been exercised, raising aggregate gross proceeds for the Company of £1,373,000.

 

As at 11 December 2020 the book value attributed to the Company's investment in Myanmar Allure Group Limited ("MAG") was £150,000 (30 June 2020 - £513,710) reflecting the Directors' assessment of MAG's future prospects.

 

 

Copies of the financial statements for the period ended 11 December 2020 are available from the Company's registered address and will be available on the Company's website, www.aaacap.com, later today.

 

 

For further information:

 

All Active Asset Capital Limited

James Normand, Non-Executive Chairman

Rodger Sargent, Executive Director

www.aaacap.com

 

Allenby Capital Limited (Nominated Adviser and Broker)

Alex Brearley / Nick Athanas

T: +44 (0) 203 328 5656

www.allenbycapital.com

 

Buchanan (Financial PR)

Richard Oldworth / Chris Lane / Toto Berger

T: +44 (0) 207 466 5000

E: AAAC@buchanan.uk.com 

 

 

ALL ACTIVE ASSET CAPITAL LIMITED

CONSOLIDATED STATEMENT OF PROFIT OR LOSS

AND OTHER COMPREHENSIVE INCOME

FOR THE PERIOD 1 JULY TO 11 DECEMBER 2020

 

 

 

 

 

 

 

Period

ended

11 December 2020

 

6 months ended

30 June

2020

 

Notes

£

(Unaudited)

 

£

(Unaudited)

 

 

 

 

 

Fair value adjustments on investments

 

(1,100,510)

 

-

Administrative expenses

 

(248,202)

 

(220,575)

Loss before interest and taxation

 

(1,348,712)

 

(220,575)

Interest income

 

-

 

112

Operating loss before taxation

 

(1,348,712)

 

(220,463)

Taxation

 

-

 

-

Loss for the period attributable to the owners of the Company

 

(1,348,712)

 

(220,463)

Other comprehensive income:

 

 

 

 

Items that may be reclassified subsequently to profit or loss:

 

 

 

 

Exchange profit on translation of foreign assets

 

-

 

33,209

Total comprehensive expense for the period

 

(1,348,712)

 

(187,254)

 

 

 

 

 

 

 

 

 

 

Loss per share

3

(0.17p)

 

(0.04p)

 

The notes 1 to 6 below form an integral part of these financial statements.

 

 

ALL ACTIVE ASSET CAPITAL LIMITED

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

AS AT 11 DECEMBER 2020

 

 

 

 

As at

11 December2020

 

As at

30 June 2020

 

Notes

£

(Unaudited)

 

£

(Unaudited)

ASSETS

 

 

 

 

Non-current assets

 

 

 

 

Investments in equity instruments

4

469,200

 

1,569,710

Loans

4

2,701,972

 

-

 

 

3,171,172

 

1,569,710

Current assets

 

 

 

 

Prepayments

 

9,526

 

35,716

Deposits and other receivables

5

270,060

 

1,219,044

Bank balances

5

10,247,921

 

-

Total current assets

 

10,527,507

 

1,254,760

Total assets

 

13,698,679

 

2,824,470

 

 

 

 

 

CAPITAL AND RESERVES

 

 

 

 

Share capital

6

21,099,315

 

8,699,644

Reserves

 

(7,442,279)

 

(6,093,567)

Total equity

 

13,657,036

 

2,606,077

 

 

 

 

 

LIABILITIES

 

 

 

 

Current liabilities

 

 

 

 

Other payables and accruals

 

41,643

 

218,393

Total liabilities

 

41,643

 

218,393

 

 

 

 

 

Total equity and liabilities

 

13,698,679

 

2,824,469

 

 

 

 

 

Net current assets

 

10,485,864

 

1,036,367

 

 

 

 

 

Total assets less current liabilities

 

13,657,036

 

2,606,077

 

 

 

 

 

Net assets

 

13,657,036

 

2,606,077

 

The notes 1 to 6 below form an integral part of these financial statements.

 

 

ALL ACTIVE ASSET CAPITAL LIMITED

CONSOLIDATED STATEMENT OF CHANGE IN EQUITY

FOR THE PERIOD 1 JULY TO 11 DECEMBER 2020

 

 

 

Share capital

Exchange reserve

Accumulated losses

Total

 

£

£

£

£

At 1 January 2020

6,392,944

346,646

(6,252,959)

486,631

Total comprehensive expense for the period

-

33,209

(220,463)

(187,254)

Issue of shares in the period

2,306,000

-

-

-

At 1 July 2020

8,699,644

379,855

(6,473,422)

2,606,077

Total comprehensive expense for the period

-

-

(1,348,712)

(1,348,712)

Issue of shares in the period

12,399,671

-

-

12,399,671

At 11 December 2020

21,099,315

379,855

(7,822,134)

13,657,036

 

 

 

 

 

 

The notes 1 to 6 below form an integral part of these financial statements.

 

 

ALL ACTIVE ASSET CAPITAL LIMITED

CONSOLIDATED STATEMENT OF CASH FLOWS

FOR THE PERIOD 1 JULY TO 11 DECEMBER 2020

 

 

 

Notes

Period from

1 July 2020 to 11 December 2020

 

6 months ended

30 June

2020

 

 

£

(Unaudited)

 

£

(Unaudited)

Operating activities

 

 

 

 

Loss before interest and taxation

 

(1,348,712)

 

(220,575)

Fair value adjustment

 

1,100,510

 

-

 

 

(248,202)

 

(220,575)

Working capital changes

 

 

 

 

Decrease (increase) in prepayments

 

26,190

 

(14,912)

Decrease (increase) in deposits and other receivables

 

948,984

 

(1,101,841)

(Decrease) increase in accruals and other payables

 

(176,750)

 

86,516

Cash generated by (used in) operations

 

550,222

 

(1,250,812)

Interest received

 

-

 

112

Net cash used in operating activities

 

550,222

 

(1,250,700)

Financing activities

 

 

 

 

Net proceeds of shares issued for cash

 

12,399,671

 

1,250,700

 

 

12,949,893

 

-

Investment activities

 

 

 

 

Advance of secured convertible loan

 

(2,701,972)

 

-

Net increase in cash

 

10,247,921

 

-

Cash at beginning of the period

5

-

 

-

Cash at end of the period

5

10,247,921

 

-

 

The notes 1 to 6 below form an integral part of these financial statements.

 

 

ALL ACTIVE ASSET CAPITAL LIMITED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

11 DECEMBER 2020

 

 

1. GENERAL INFORMATION

 

All Active Asset Capital Limited (the "Company") is an investing company incorporated in the British Virgin Islands on 14 September 2012 with its registered office located on Commerce House, Wickhams Cay 1, P.O. Box 3140, Road Town, Tortola, British Virgin Islands. The ordinary shares of the Company were admitted to trading on the AIM market of the London Stock Exchange on 2 May 2013.

 

The principal activity of the Company is to make investments in accordance with its investing policy.

 

These financial statements are unaudited and do not constitute statutory accounts.

 

2. BASIS OF ACCOUNTING

 

These consolidated financial statements have been prepared in accordance with International Accounting Standard 34, Interim Financial Reporting, issued by the International Accounting Standards Board, and the applicable disclosure provisions of the AIM Rules for Companies issued by the London Stock Exchange. The financial statements are presented in pounds sterling.

 

The preparation of consolidated financial statements in conformity with IAS 34 requires management to make judgements, estimates and assumptions that affect the application of policies and reported amounts of assets and liabilities, income and expenses on a year-to-date basis. Actual results may differ from these estimates.

 

This additional interim financial information contains consolidated financial statements and explanatory notes. The notes include an explanation of events and transactions that are significant to an understanding of the changes in financial position and performance of the Group since the interim financial statements for the six months ended 30 June 2020. These consolidated financial statements and notes therein do not include all of the information required for a full set of financial statements prepared in accordance with International Financial Reporting Standards.

 

3. LOSS PER SHARE

 

The calculation of the basic loss per share is based on the loss for the period attributable to shareholders of £1,348,712 (six months ended 30 June 2020: loss of £187,254) divided by the weighted average number of 799,134,090 (six months ended 30 June 2020: 520,630,987) ordinary shares in issue during the period.

 

4. INVESTMENTS

 

 

11 December

2020

 

30 June

2020

 

£

 

£

Unlisted entities

 

 

 

7% stake in Myanmar Allure Group Company Limited

150,000

 

513,710

Secured convertible loan to Mesh Holdings plc (€3 million)

2,701,972

 

-

 

 

 

 

Listed equity entities

 

 

 

Ordinary shares in Asimilar Group plc, warrants over ordinary shares in Asimilar Group plc and options over warrants in Asimilar Group plc

319,200

 

1,056,000

 

 

 

 

 

3,171,172

 

1,569,710

 

The equity and loan interests in unlisted entities are stated at directors' valuation. The investments in the listed securities are valued using market prices.

 

 

ALL ACTIVE ASSET CAPITAL LIMITED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (continued)

11 DECEMBER 2020

 

 

5. BANK BALANCES

 

At 30 June 2020, the Group did not have a bank account. At that date cash amounting to £1,219,044 was held in trust by third party financial institutions and was classified as deposits and other receivables.

 

6. SHARE CAPITAL

 

Authorised

No. of shares

 

No. of shares

 

Ordinary shares of no par value

2,000,000,000

 

1,000,000,000

 

 

 

 

Issued

£

 

£

 

973,723,572 (30 June 2020 - 774,076,072) ordinary shares of no par value

21,099,315

 

8,699,644

 

On 20 November 2020, the Company issued 62,500,000 new ordinary shares at a price of 8 pence per share, raising gross proceeds of £5,000,000.

 

On 3 December 2020 the Company issued 81,250,000 new ordinary shares at a price of 8 pence per share, raising gross proceeds of £6,500,000.

 

Since 30 June 2020 holders of warrants have exercised their rights to buy 54,670,001 shares at 2.5p per share and 1,562,500 shares at 0.4p per share, raising aggregate gross proceeds for the Company of £1,373,000.

 

On 20 November 2020 the Company granted 31,250,000 warrants over new ordinary shares at an exercise price of 15p per share. The warrants are exercisable for 18 months from the date of issue. As at 11 December 2020 none of these warrants has been exercised.

 

On 30 November 2020, the Company granted 49,200,000 warrants over new ordinary shares at an exercise price of 15p per share. The warrants are exercisable for 18 months from the date of issue. As at 11 December 2020 none of these warrants had been exercised.

 

On 4 December 2020 the Company granted 40,625,000 warrants over new ordinary shares at an exercise price of 15p per share. The warrants are exercisable for 18 months from the date of issue. As at 11 December 2020 none of these warrants had been exercised.

 

In addition to the warrants issued during the period, there remain 67,665,000 unexercised warrants (each exercisable at 2.5p per share) which, if exercised, would result in the receipt by the Company of £1,691,625 in additional share capital. The ability to exercise these warrants expires on 16 December 2020.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR TABATMTTBBBM
Date   Source Headline
14th Jul 20208:05 amRNSStatement re Announcement by Asimilar
9th Jul 20201:10 pmRNSBoard Appointment
2nd Jul 20209:20 amRNSBlock admission application
30th Jun 20203:10 pmRNSStatement re Asimilar Interim Results
26th Jun 20201:22 pmRNSExtension of reporting deadline & portfolio update
22nd Jun 20204:35 pmRNSPrice Monitoring Extension
19th Jun 20202:41 pmRNSHolding(s) in Company
18th Jun 20204:41 pmRNSSecond Price Monitoring Extn
18th Jun 20204:35 pmRNSPrice Monitoring Extension
17th Jun 202012:46 pmRNSHolding(s) in Company
16th Jun 20204:41 pmRNSSecond Price Monitoring Extn
16th Jun 20204:36 pmRNSPrice Monitoring Extension
16th Jun 20209:30 amRNSAdmission of Placing Shares and Board Change
12th Jun 202011:30 amRNSResult of Extraordinary General Meeting
28th May 20207:00 amRNSBoard changes
22nd May 20208:41 amRNSNotice of Extraordinary General Meeting
14th May 20204:40 pmRNSSecond Price Monitoring Extn
14th May 20204:35 pmRNSPrice Monitoring Extension
14th May 20204:22 pmRNSRevised placing to raise £1.2 million
14th May 20202:06 pmRNSSecond Price Monitoring Extn
14th May 20202:01 pmRNSPrice Monitoring Extension
14th May 202012:19 pmRNSOptions over warrants in Asimilar Group plc
7th May 20205:42 pmRNSFurther re. proposed conditional placing
28th Apr 20207:00 amRNSUpdate on proposed placing to raise £1.26 million
17th Apr 20202:57 pmRNSHolding(s) in Company
17th Apr 20202:52 pmRNSHolding(s) in Company
17th Apr 20202:50 pmRNSHolding(s) in Company
16th Apr 202011:53 amRNSHolding(s) in Company
14th Apr 20207:00 amRNSHolding(s) in Company
3rd Apr 20203:24 pmRNSProposed conditional placing
30th Mar 202012:10 pmRNSInvestment in shares in Asimilar Group Plc
26th Mar 20201:25 pmRNSHolding(s) in Company
20th Mar 20202:15 pmRNSInvestment in warrants in Asimilar Group Plc
10th Mar 202012:54 pmRNSChange of Board Roles
28th Feb 20205:00 pmRNSTotal Voting Rights
27th Feb 202012:58 pmRNSHolding(s) in Company
27th Feb 202012:58 pmRNSHolding(s) in Company
27th Feb 202011:13 amRNSHolding(s) in Company
24th Feb 202012:24 pmRNSResult of Extraordinary General Meeting
10th Feb 202011:01 amRNSAvailability of circular
5th Feb 20203:49 pmRNSProposed conditional placing to raise £200,000
31st Jan 202012:17 pmRNSBoard changes
15th Oct 20192:10 pmRNSChange of Name
10th Oct 201911:09 amRNSResult of Extraordinary General Meeting
30th Sep 20195:00 pmRNSTotal Voting Rights
24th Sep 20191:51 pmRNSInterim Results for the period ended 30 June 2019
23rd Sep 20191:00 pmRNSCompletion of placing and other matters
20th Sep 201911:04 amRNSAvailability of circular
17th Sep 201911:19 amRNSPlacing to raise £125,000 and other matters
30th Jul 20191:39 pmRNSResult of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.